Remepy has raised $36M in a Series A financing round [...]

A Tufts CSDD analysis estimates that an AI clinical monitoring [...]

The FDA has accepted Belite Bio’s application for tinlarebant and [...]

Skylark Bio has dosed the first patient in a Phase [...]

CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

AC Immune has received FDA Fast Track designation and IND [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

OSF HealthCare is expanding its use of RapidAI’s clinical AI [...]